10-Gingerol induces ferroptosis via TFEB-mediated NRF2 lysosomal degradation in NSCLC
Toxicology and Applied Pharmacology · 2026-06 · 511 · 117828
DOI: 10.1016/j.taap.2026.117828 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicology and Applied Pharmacology, 2026-06. Verfasst von Siying Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Pharmacy, Beihua University, No. 3999, East Binjiang Road, Jilin, China. Hauptthemen laut MEDLINE: Ferroptosis, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, NF-E2-Related Factor 2, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Education Department of Jilin Province, Jilin Provincial Scientific and Technological Development Program.
Abstract (Originalsprache)
10-Gingerol (10-G) exhibits antitumor activity, yet its mechanism in non-small cell lung cancer (NSCLC) remains unclear. Ferroptosis, a mode of programmed cell death resulting from lipid peroxidation, is regulated by abnormalities in the antioxidant system and iron metabolism. This study investigated the antitumor mechanism of 10-G in NSCLC, emphasizing its dual role in activating lysosomes and inducing ferroptosis. In this study, we found 10-G induced ferroptosis in NSCLC by increasing iron accumulation, lipid peroxidation, intracellular ROS levels, and malondialdehyde (MDA) production, while depleting glutathione (GSH) and rising Fe2+ levels. Mechanistically, 10-G induced the dephosphorylation of Transcription Factor EB (TFEB) and TFEB dissociation from the 14-3-3 protein, thereby promoting the nuclear translocation of TFEB and the activation of lysosomal gene expression. Subsequently, the activation of lysosomes promoted the degradation of Nuclear factor erythroid 2-related factor 2 (NRF2), thereby affecting the expression levels of downstream targets Glutathione Peroxidase 4 (GPX4) and cystine/glutamate antiporter SLC7A11 (xCT), ultimately leading to ferroptosis. In vivo, 10-G suppressed tumor growth by inhibiting the TFEB-mediated NRF2/xCT/GPX4 axis and promoting ferroptosis. These findings demonstrated that 10-G suppressed the progression of NSCLC by promoting TFEB-mediated lysosomal degradation of NRF2, thereby inducing ferroptosis, which provides a rationale for a novel potential therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, College of Pharmacy, Beihua University, No. 3999, East Binjiang Road, Jilin, China.
- Department of Immunology, School of Basic Medicine, Beihua University, No. 3999, East Binjiang Road, Jilin, China. Electronic address: 20220038@beihua.edu.cn.
- Department of Pharmacology, College of Pharmacy, Beihua University, No. 3999, East Binjiang Road, Jilin, China. Electronic address: zhzhang518@beihua.edu.cn.
Förderung
- National Natural Science Foundation of China
- Education Department of Jilin Province
- Jilin Provincial Scientific and Technological Development Program
- Beihua University
- Jilin Provincial Science and Technology Department
Zitieren
APA
Li, S., Shi, K., Huang, L., Li, Z., Qin, Z., Sun, Y., Qin, C., Wang, C., Li, H., Sun, J., Liu, W., Wu, J., & Zhang, Z. (2026). 10-Gingerol induces ferroptosis via TFEB-mediated NRF2 lysosomal degradation in NSCLC. Toxicology and Applied Pharmacology, 511, 117828. https://doi.org/10.1016/j.taap.2026.117828
Vancouver
Li S, Shi K, Huang L, Li Z, Qin Z, Sun Y, et al. 10-Gingerol induces ferroptosis via TFEB-mediated NRF2 lysosomal degradation in NSCLC. Toxicology and Applied Pharmacology. 2026;511:117828. doi:10.1016/j.taap.2026.117828
BibTeX
@article{Li2026,
author = {Li, Siying and Shi, Kaihua and Huang, Lei and Li, Ziqing and Qin, Zhuo and Sun, Yanan and Qin, Caifang and Wang, Chunmei and Li, He and Sun, Jinghui and Liu, Wei and Wu, Jiping and Zhang, Zhihong},
title = {10-Gingerol induces ferroptosis via TFEB-mediated NRF2 lysosomal degradation in NSCLC},
journal = {Toxicology and Applied Pharmacology},
year = {2026},
volume = {511},
pages = {117828},
doi = {10.1016/j.taap.2026.117828}
}
EUVIMED